Skip to main content
. 2020 May 15;12:100282. doi: 10.1016/j.bonr.2020.100282

Table 3.

Osteoclast parameters and the erosive progression in RA.

Erosion SHS < 5 at V4
Erosion SHS ≥ 5 at V4
p p-adj
n median (IQR) n median (IQR)
All n = 16 n = 82
 OCs/well V1 16 286.5 (210.0–744.5) 82 372.5 (153.0–668.0) 0.5446 0.5307
 CD14% PBMCs V1 16 15.0 (9.9–19.6) 82 17.4 (12.6–23.7) 0.1440 0.2792
 Resorption (μm2) V1 15 82,484 (0–1,264,508) 82 0 (0–836,372) 0.3865 0.7158
 Apoptosis (%) V1 13 17.0 (12.0–18.0) 58 7.5 (4.0–15.0) 0.1081 0.2531
RA > 5 years
 OCs/well V1 5 592.0 (306.0–783.0) 64 334.5 (124.0–682.5) 0.2467 0.4193
 CD14% PBMCs V1 5 19.1 (12.3–21.6) 64 17.3 (12.5–23.7) 0.9631 0.8562
 Resorption (μm2) V1 4 85,782 (33411–684,625) 64 0 (0–404,559) 0.5374 0.6845
 Apoptosis (%) V1 4 0.0 (0.0–8.5) 44 8.0 (4.5–16.5) 0.1144 0.1957
RA ≤ 5 years
 OCs/well V1 11 258.0 (191.0–706.0) 18 487.0 (229.0–535.0) 0.6691 0.9243
 CD14% PBMCs V1 11 14.9 (7.7–18.6) 18 17.8 (12.9–25.9) 0.1265 0.1817
 Resorption (μm2) V1 11 82,484 (0–2,733,971) 18 482,357 (0–1,410,990) 0.7816 0.9137
 Apoptosis (%) V1 9 18.0 (17.0–21.0) 14 5.0 (3.0–12.0) 0.0036 0.0287

IQR: Interquartile Range (25th–75th percentiles).

Erosion SHS: Erosion score from the Sharp/van der Heijde modified method; OC: osteoclast.

p adjusted for DAS28.